Longer survival associated with HLA-A 03, B 14 among 212 hemochromatosis probands with HFE C282Y homozygosity and HLA-A and -B typing and haplotyping

European Journal of Haematology

Volumn 85, Issue 5, 2010, Pages 439-447

  Barton, James C ^a,b   Clayborn Barton, J ^a   Acton, Ronald T ^c  

^a SOUTHERN IRON DISORDERS CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Ancestral haplotype; Hemochromatosis; HFE; HLA; Human leukocyte antigen; Iron overload; Survival

Indexed keywords

HFE PROTEIN; HLA A3 ANTIGEN; HLA ANTIGEN CLASS 1; HLA B14 ANTIGEN; HLA B7 ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CHILD; FEMALE; HAPLOTYPE; HEMOCHROMATOSIS; HLA SYSTEM; HUMAN; HYPOGONADISM; IRON OVERLOAD; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; ONSET AGE; PRIORITY JOURNAL; SCHOOL CHILD; SEX RATIO; SURVIVAL;

ADULT; AGED; FEMALE; HAPLOTYPES; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HLA-B ANTIGENS; HOMOZYGOTE; HUMANS; IRON OVERLOAD; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION, MISSENSE; SEX FACTORS; SURVIVAL RATE;

EID: 77958608934     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2010.01511.x     Document Type: Article

References (42)

1. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 1996;245:139-200.
2. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
3. Barton JC, Harmon L, Rivers C, Acton RT. Hemochromatosis: association of severity of iron overload with genetic markers. Blood Cells Mol Dis 1996;22:195-204.
4. Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Intern Med 1997;127:105-10.
5. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985;313:1256-62.
6. Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991;101:368-72.
7. Fargion S, Mandelli C, Piperno A, Cesana B, Fracanzani AL, Fraquelli M, Bianchi PA, Fiorelli G, Conte D. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992;15:655-9.
8. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-19.
9. Beaton MD, Adams PC. Prognostic factors and survival in patients with hereditary hemochromatosis and cirrhosis. Can J Gastroenterol 2006;20:257-60.
10. Whitfield JB, Cullen LM, Jazwinska EC, Powell LW, Heath AC, Zhu G, Duffy DL, Martin NG. Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet 2000;66:1246-58.
11. Barton JC, Wiener HW, Acton RT, Go RC. HLA haplotype A03-B07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload. Blood Cells Mol Dis 2005;34:38-47.
12. Waalen J, Nordestgaard BG, Beutler E. The penetrance of hereditary hemochromatosis. Best Pract Res Clin Haematol 2005;18:203-20.
13. Barton JC, Lafreniere SA, Leiendecker-Foster C, Li H, Acton RT, Press RD, Eckfeldt JH. HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants. Am J Hematol 2009;84:710-4.
14. Acton RT, Barton JC, Leiendecker-Foster C, Zaun C, McLaren CE, Eckfeldt JH. Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 Hemochromatosis and Iron Overload Screening (HEIRS) Study participants. Blood Cells Mol Dis 2010;44:252-6.
15. McLaren CE, Barton JC, Eckfeldt JH, et al. Heritability of serum iron measures in the Hemochromatosis and Iron Overload Screening (HEIRS) Family Study. Am J Hematol 2010;85:101-5.
16. Barton JC, Leiendecker-Foster C, Li H, DelRio-LaFreniere S, Acton RT, Eckfeldt JH. HAMP promoter mutation nc.-153C>T in 785 HEIRS Study participants. Haematologica 2009;94:1465-6.
17. Simon M, Le Mignon L, Fauchet R, Yaouanq J, David V, Edan G, Bourel M. A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association. Am J Hum Genet 1987;41:89-105.
18. Yaouanq J. Human leukocyte antigen (HLA) association and typing in hemochromatosis. In: Barton JC, Edwards CQ, eds. Hemochromatosis, Genetics, Pathophysiology, Diagnosis, and Treatment. Cambridge: Cambridge University Press, 2000:63-74.
19. Barton JC, Acton RT. HLA-A and -B alleles and haplotypes in hemochromatosis probands with HFE C282Y homozygosity in central Alabama. BMC Med Genet 2002;3:9.
20. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996;335:1799-05.
21. Worwood M, Raha-Chowdhury R, Dorak MT, Darke C, Bowen DJ, Burnett AK. Alleles at D6S265 and D6S105 define a haemochromatosis-specific genotype. Br J Haematol 1994;86:863-6.
22. Thomas W, Fullan A, Loeb DB, McClelland EE, Bacon BR, Wolff RK. A haplotype and linkage disequilibrium analysis of the hereditary hemochromatosis gene region. Hum Genet 1998;102:517-25.
23. Fairbanks VF. Hemochromatosis: population genetics. In: Barton JC, Edwards CQ, eds. Hemochromatosis. Genetics, Pathophysiology, Diagnosis, and Treatment. Cambridge: Cambridge University Press, 2000:42-50.
24. Raha-Chowdhury R, Gruen J. Localization, allelic heterogeneity, and origins of the hemochromatosis gene. In: Barton JC, Edwards CQ, eds. Hemochromatosis, Genetics, Pathophysiology, Diagnosis, and Treatment. Cambridge: Cambridge University Press, 2000:75-90.
25. Crawford DH, Powell LW, Leggett BA, Francis JS, Fletcher LM, Webb SI, Halliday JW, Jazwinska EC. Evidence that the ancestral haplotype in Australian hemochromatosis patients may be associated with a common mutation in the gene. Am J Hum Genet 1995;57:362-7.
26. Piperno A, Arosio C, Fargion S, et al. The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients. Hepatology 1996;24:43-6.
27. Olsson KS, Ritter B, Raha-Chowdhury R. HLA-A3-B14 and the origin of the haemochromatosis C282Y mutation: founder effects and recombination events during 12 generations in a Scandinavian family with major iron overload. Eur J Haematol 2010;84:145-53.
28. Murphy S, Curran MD, McDougall N, Callender ME, O'Brien CJ, Middleton D. High incidence of the Cys 282 Tyr mutation in the HFE gene in the Irish population - implications for haemochromatosis. Tissue Antigens 1998;52:484-8.
29. Milman N, Graudal N, Nielsen LS, Fenger K. HLA determinants in 70 Danish patients with idiopathic haemochromatosis. Clin Genet 1988;33:286-92.
30. Barton JC, Shih WW, Sawada-Hirai R, Acton RT, Harmon L, Rivers C, Rothenberg BE. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cells Mol Dis 1997;23:135-45.
31. Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacteriol 1962;84:53-64.
32. Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards CQ, Cook JD, Kowdley KV; Hemochromatosis Management Working Group. Management of hemochromatosis. Ann Intern Med 1998;129:932-9.
33. Barton JC, Acton RT, Anderson LE, Alexander CB. A comparison between whites and blacks with severe multi-organ iron overload identified in 16, 152 autopsies. Clin Gastroenterol Hepatol 2009;7:781-5.
34. Wojcik JP, Speechley MR, Kertesz AE, Chakrabarti S, Adams PC. Natural history of C282Y homozygotes for hemochromatosis. Can J Gastroenterol 2002;16:297-302.
35. Ellervik C, Tybjaerg-Hansen A, Grande P, Appleyard M, Nordestgaard BG. Hereditary hemochromatosis and risk of ischemic heart disease: a prospective study and a case-control study. Circulation 2005;112:185-93.
36. Pankow JS, Boerwinkle E, Adams PC, Guallar E, Leiendecker-Foster C, Rogowski J, Eckfeldt JH. HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study. Transl Res 2008;152:3-10.
37. Cruz E, Whittington C, Krikler SH, Mascarenhas C, Lacerda R, Vieira J, Porto G. A new 500 kb haplotype associated with high CD8+ T-lymphocyte numbers predicts a less severe expression of hereditary hemochromatosis. BMC Med Genet 2008;9:97.
38. Jazwinska EC. The ancestral haplotype in hemochromatosis. In: Barton JC, Edwards CQ, eds. Hemochromatosis, Genetics, Pathophysiology, Diagnosis, and Treatment. Cambridge: Cambridge University Press, 2000:91-9.
39. Porto G, Cruz E, Miranda HP, Porto B, Vasconcelos JC, Lacerda R, Roetto A, Daraio F, Bacelar C. Growth hormone (GH)-induced reconstitution of CD8+ CD28+ T lymphocytes in a rare case of severe lymphopenia associated with Juvenile Haemochromatosis and Turner's syndrome. Clin Endocrinol (Oxf) 2004;61:437-40.
40. Barton JC, Wiener HW, Acton RT, Go RC. Total blood lymphocyte counts in hemochromatosis probands with HFE C282Y homozygosity: relationship to severity of iron overload and HLA-A and -B alleles and haplotypes. BMC Blood Disord 2005;5:5.
41. Cruz E, Vieira J, Almeida S, Lacerda R, Gartner A, Cardoso CS, Alves H, Porto G. A study of 82 extended HLA haplotypes in HFE-C282Y homozygous hemochromatosis subjects: relationship to the genetic control of CD8+ T-lymphocyte numbers and severity of iron overload. BMC Med Genet 2006;7:16.
42. Porto G, De Sousa M. Variation in hemochromatosis prevalence and genotype in national groups. In: Barton JC, Edwards CQ, eds. Hemochromatosis, Genetics, Pathophysiology, Diagnosis, and Treatment. Cambridge: Cambridge University Press, 2000:51-62.